Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates
NCT ID: NCT01519570
Last Updated: 2019-02-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2589 participants
INTERVENTIONAL
2011-03-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Shingles Prevention Study
NCT00007501
Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital
NCT01483378
The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting
NCT00689013
Evaluating New Formulation of Therapeutic HSV-2 Vaccine
NCT02515175
Herpes Zoster: Risk Factors, Complications and Special Situations
NCT03903237
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
An informational packet regarding shingles and the HZV
An informational packet regarding shingles and the HZV was sent to patients identified by the EMR
The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription.
Standard medical care from their primary care physician
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
An informational packet regarding shingles and the HZV was sent to patients identified by the EMR
The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ohio State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stuart Beatty
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stuart J Beatty, PharmD
Role: PRINCIPAL_INVESTIGATOR
Ohio State University
Shelley H Otsuka, PharmD
Role: STUDY_CHAIR
The Ohio State Univeristy
Neeraj H Tayal, MD
Role: STUDY_CHAIR
Ohio State University
Kyle Porter, MAS
Role: STUDY_CHAIR
Ohio State University
Peter J Embi, MD, MS
Role: STUDY_CHAIR
Ohio State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Ohio State University Martha Morehouse General Internal Medicine Clinic
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010H0290
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.